Log In
Print
BCIQ
Print
Print this Print this
 

telotristat etiprate (LX1606) (LX1032)

  Manage Alerts
Collapse Summary General Information
Company Lexicon Pharmaceuticals Inc.
DescriptionTryptophan hydroxylase inhibitor
Molecular Target
Mechanism of ActionTryptophan hydroxylase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationNeuroendocrine tumors
Indication DetailsTreat carcinoid syndrome; Treat carcinoid tumors; Treat refractory carcinoid syndrome
Regulatory Designation

U.S. - Fast Track (Treat carcinoid syndrome);
U.S. - Orphan Drug (Treat carcinoid syndrome);
EU - Orphan Drug (Treat carcinoid tumors)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today